Scarica l'app Stockscreener
79.50
0.30%
0.24
Dopo l'orario di chiusura:
79.52
0.02
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$79.26
Aprire:
$79.81
Volume 24 ore:
1.20M
Relative Volume:
0.58
Capitalizzazione di mercato:
$39.05B
Reddito:
$10.19B
Utile/perdita netta:
$1.05B
Rapporto P/E:
37.78
EPS:
2.1044
Flusso di cassa netto:
$1.38B
1 W Prestazione:
+0.94%
1M Prestazione:
+4.91%
6M Prestazione:
-6.22%
1 anno Prestazione:
-6.18%
Intervallo 1D:
$79.38
$80.28
Intervallo di 1 settimana:
$78.25
$80.28
Portata 52W:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ALC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
79.50 | 38.93B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
561.89 | 197.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.70 | 55.76B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
242.55 | 35.90B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
268.66 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Reiterato | BTIG Research | Buy |
| 2025-03-28 | Reiterato | Needham | Buy |
| 2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-24 | Reiterato | Needham | Buy |
| 2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Reiterato | Needham | Buy |
| 2024-11-12 | Reiterato | Needham | Buy |
| 2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Iniziato | Goldman | Buy |
| 2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Iniziato | Bernstein | Outperform |
| 2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
| 2022-12-22 | Iniziato | Mizuho | Buy |
| 2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
| 2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-11 | Iniziato | BofA Securities | Buy |
| 2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Iniziato | Oppenheimer | Perform |
| 2021-07-14 | Iniziato | Deutsche Bank | Buy |
| 2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
| 2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Argus | Hold → Buy |
| 2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-01-08 | Iniziato | Argus | Hold |
| 2019-10-29 | Iniziato | Stephens | Equal-Weight |
| 2019-08-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-06-14 | Iniziato | BTIG Research | Neutral |
| 2019-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
Why Alcon Inc. stock could rally in 2025Market Sentiment Summary & Low Risk High Win Rate Picks - Улправда
Can Alcon Inc. stock deliver consistent earnings growthMarket Trend Review & Smart Allocation Stock Tips - Улправда
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR) - Seeking Alpha
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com India
Defender Capital reiterates intention to vote against Staar Surgical's proposed sale to Alcon Inc. - marketscreener.com
Alcon (ALC) Acquisition of STAAR Surgical Faces Strong Oppositio - GuruFocus
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Broadwood urges shareholders to reject Alcon’s bid for STAAR By Investing.com - Investing.com South Africa
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR urges stockholders to vote for Alcon merger amid proxy battle By Investing.com - Investing.com South Africa
Alcon (ALC) Merger Proposal Faces Crucial Vote by STAAR Sharehol - GuruFocus
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value - marketscreener.com
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Bernstein Bullish on Alcon's FY26 Earnings Growth Momentum; Outperform Maintained - marketscreener.com
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - MSN
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon - Investing.com India
STAAR Surgical (NASDAQ: STAA) faces proxy fight over Alcon merger bid - Stock Titan
STAAR Surgical (NASDAQ: STAA) investor Yunqi Capital urges no vote on Alcon deal - Stock Titan
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
Yunqi Capital to vote against revised Alcon-STAAR merger offer By Investing.com - Investing.com South Africa
Yunqi Capital to vote against revised Alcon-STAAR merger offer - Investing.com
Yunqi Capital Opposes Alcon's Acquisition Proposal for STAAR Sur - GuruFocus
Yunqi Capital says remains opposed to STAAR’s proposed merger with Alcon - TipRanks
5.1% STAAR owner fights Alcon deal, arguing company is worth more - Stock Titan
Broadwood Partners Comments on ISS Report on of STAAR Surgical to Alcon - marketscreener.com
Alcon raises STAAR Surgical acquisition offer to $30.75 per share - Investing.com India
Alcon raises STAAR Surgical acquisition offer to $30.75 per share By Investing.com - Investing.com Nigeria
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction - marketscreener.com
Alcon (NYSE: ALC) $30.75-per-share STAAR bid gains support from analysts and ISS - Stock Titan
ISS Advises Staar Surgical Shareholders to Vote for Alcon Takeover Bid in Updated Recommendation - marketscreener.com
Alcon (ALC) Replaced on Needham's Conviction List - GuruFocus
ISS Recommends STAAR Stockholders Vote for Alcon Merger - marketscreener.com
Broadwood Partners comments on ISS report on proposed sale of STAAR Surgical to Alcon - marketscreener.com
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon - FinancialContent
STAAR Surgical Shareholders Urged to Vote in Favor of Merger With Alcon - marketscreener.com
STAAR Surgical (STAA) Gains as ISS Backs Alcon's Improved Offer - GuruFocus
Staar Surgical Endorses Alcon (ALC) Merger, Backed by New ISS Re - GuruFocus
Alcon draws double downgrade at BofA on earnings growth risk - MSN
STAAR Surgical jumps after Alcon raises offer to $30.75/share in cash (update) - MSN
Barclays Sticks to Their Hold Rating for Alcon (ALC) - The Globe and Mail
Aug Decliners: Will Alcon Inc 2U3 stock outperform global peersQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Broadwood urges STAAR Surgical (NASDAQ: STAA) vote against Alcon sale - Stock Titan
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal (update) - MSN
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal (update) (STAA:NASDAQ) - Seeking Alpha
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid By Investing.com - Investing.com Nigeria
STAAR Surgical (STAA) Faces Investor Pushback on Alcon Offer - GuruFocus
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid - Investing.com
Alcon appoints Anup Changavalli as HeadHR, ANZ - ETHRWorld.com
Alcon (ALC) Sees Downgrade, Shares Drop 1.6% - GuruFocus
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):